Solidcore secures $100M credit facility from ING

Kanat Dosmukametov Chief Operating Officer of Solidcore Resources Polymetal International
Kanat Dosmukametov Chief Operating Officer of Solidcore Resources - Polymetal International
0Comments

Solidcore Resources plc has announced a credit facility agreement with Dutch bank ING, allowing for up to US$ 100 million. The funds will be used for general corporate purposes, including refinancing loans maturing this year.

Evgenia Onuschenko, CFO of Solidcore Resources plc, stated: “Our agreement with ING marks another milestone in Solidcore’s track record of securing international financing. Partnering with this leading global institution underscores the strong confidence in our strategy and long-term vision.”

Cilia Ruinen, Head Metals Mining & Fertilizers EMEA at ING, commented: “At ING, we are pleased to support Solidcore throughout their journey of growth and transformation. We are committed to building enduring relationships and being a reliable partner at every stage of our clients’ evolution. Hence, we look forward to supporting Solidcore as they continue to grow and expand.”

ING Bank is headquartered in Amsterdam and is one of the world’s largest financial institutions with operations in over 100 countries. It offers a broad range of retail and corporate banking services.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.